|Effectiveness and costs of interventions to lower systolic blood pressure and cholesterol: a global and regional analysis on reduction of cardiovascular-disease risk|
CJL Murray, JA Lauer, RCW Hutubessy, L Niessen, N Tomijima, ...
The Lancet 361 (9359), 717-725, 2003
|Health-related quality of life and treatment satisfaction in Dutch patients with type 2 diabetes|
WK Redekop, MA Koopmanschap, RP Stolk, GEHM Rutten, ...
Diabetes care 25 (3), 458-463, 2002
|Priority setting of health interventions: the need for multi-criteria decision analysis|
R Baltussen, L Niessen
Cost effectiveness and resource allocation 4 (1), 14, 2006
|Potential impact of global climate change on malaria risk.|
WJ Martens, LW Niessen, J Rotmans, TH Jetten, AJ McMichael
Environmental health perspectives 103 (5), 458-464, 1995
|Substantia nigra projections to the reticular formation, superior colliculus and central gray in the rat, cat and monkey|
DA Hopkins, LW Niessen
Neuroscience letters 2 (5), 253-259, 1976
|Climate change and vector-borne diseases: a global modelling perspective|
WJM Martens, TH Jetten, J Rotmans, LW Niessen
Global environmental change 5 (3), 195-209, 1995
|Need for differential discounting of costs and health effects in cost effectiveness analyses|
WBF Brouwer, LW Niessen, MJ Postma, FFH Rutten
Bmj 331 (7514), 446-448, 2005
|Cost-effectiveness of prevention and treatment of the diabetic foot: a Markov analysis|
MM Ortegon, WK Redekop, LW Niessen
Diabetes care 27 (4), 901-907, 2004
|The evidence-based approach in health policy and health care delivery|
LW Niessen, EWM Grijseels, FFH Rutten
Social science & medicine 51 (6), 859-869, 2000
|Investing in non-communicable disease prevention and management to advance the Sustainable Development Goals|
R Nugent, MY Bertram, S Jan, LW Niessen, F Sassi, DT Jamison, EG Pier, ...
The Lancet 391 (10134), 2029-2035, 2018
|Tackling socioeconomic inequalities and non-communicable diseases in low-income and middle-income countries under the Sustainable Development agenda|
LW Niessen, D Mohan, JK Akuoku, AJ Mirelman, S Ahmed, ...
The Lancet 391 (10134), 2036-2046, 2018
|Discounting in economic evaluations: stepping forward towards optimal decision rules|
H Gravelle, W Brouwer, L Niessen, M Postma, F Rutten
Health economics 16 (3), 307-317, 2007
|Priority setting using multiple criteria: should a lung health programme be implemented in Nepal?|
R Baltussen, AHA Ten Asbroek, X Koolman, N Shrestha, P Bhattarai, ...
Health policy and planning 22 (3), 178-185, 2007
|Multi-criteria decision analysis to prioritize health interventions: Capitalizing on first experiences|
R Baltussen, S Youngkong, F Paolucci, L Niessen
Health policy 96 (3), 262-264, 2010
|Prediction of coronary heart disease risk in a general, pre-diabetic, and diabetic population during 10 years of follow-up: accuracy of the Framingham, SCORE, and UKPDS risk …|
AAWA Van Der Heijden, MM Ortegon, LW Niessen, G Nijpels, JM Dekker
Diabetes care 32 (11), 2094-2098, 2009
|Promoting thrombolysis in acute ischemic stroke|
M Dirks, LW Niessen, JDH Van Wijngaarden, PJ Koudstaal, CL Franke, ...
Stroke 42 (5), 1325-1330, 2011
|Mental disorders in Bangladesh: a systematic review|
MD Hossain, HU Ahmed, WA Chowdhury, LW Niessen, DS Alam
BMC psychiatry 14 (1), 216, 2014
|Estimated economic benefits during the ‘decade of vaccines’ include treatment savings, gains in labor productivity|
ML Stack, S Ozawa, DM Bishai, A Mirelman, Y Tam, L Niessen, ...
Health affairs 30 (6), 1021-1028, 2011
|Comparative impact assessment of child pneumonia interventions|
L Niessen, A Hove, H Hilderink, M Weber, K Mulholland, M Ezzati
Bulletin of the World Health Organization 87, 472-480, 2009
|Cost-effectiveness of integrated stroke services|
NJA Van Exel, MA Koopmanschap, W Scholte op Reimer, LW Niessen, ...
Qjm 98 (6), 415-425, 2005